Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis

Peer Review reports

Original Submission
15 Mar 2018	Submitted	Original manuscript
23 Apr 2018	Author responded	Author comments - Yong Tae Kim
Resubmission - Version 2
23 Apr 2018	Submitted	Manuscript version 2
6 May 2018	Reviewed	Reviewer Report - Diego Ariel de Lima
3 Jun 2018	Reviewed	Reviewer Report - Po-Hsin Chou
6 Jun 2018	Author responded	Author comments - Yong Tae Kim
Resubmission - Version 3
6 Jun 2018	Submitted	Manuscript version 3
19 Jun 2018	Author responded	Author comments - Yong Tae Kim
Resubmission - Version 4
19 Jun 2018	Submitted	Manuscript version 4
Publishing
21 Jun 2018	Editorially accepted
18 Jul 2018	Article published	10.1186/s12891-018-2151-2

Back to article page